• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机阴离子转运体:发现、药理学、调控及在病理生理学中的作用。

Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.

机构信息

Department of Pharmaceutical Sciences, Wilkes University, Wilkes-Barre, PA 18766, USA.

出版信息

Biopharm Drug Dispos. 2010 Jan;31(1):1-71. doi: 10.1002/bdd.693.

DOI:10.1002/bdd.693
PMID:19953504
Abstract

Our understanding of the mechanisms behind inter- and intra-patient variability in drug response is inadequate. Advances in the cytochrome P450 drug metabolizing enzyme field have been remarkable, but those in the drug transporter field have trailed behind. Currently, however, interest in carrier-mediated disposition of pharmacotherapeutics is on a substantial uprise. This is exemplified by the 2006 FDA guidance statement directed to the pharmaceutical industry. The guidance recommended that industry ascertain whether novel drug entities interact with transporters. This suggestion likely stems from the observation that several novel cloned transporters contribute significantly to the disposition of various approved drugs. Many drugs bear anionic functional groups, and thus interact with organic anion transporters (OATs). Collectively, these transporters are nearly ubiquitously expressed in barrier epithelia. Moreover, several reports indicate that OATs are subject to diverse forms of regulation, much like drug metabolizing enzymes and receptors. Thus, critical to furthering our understanding of patient- and condition-specific responses to pharmacotherapy is the complete characterization of OAT interactions with drugs and regulatory factors. This review provides the reader with a comprehensive account of the function and substrate profile of cloned OATs. In addition, a major focus of this review is on the regulation of OATs including the impact of transcriptional and epigenetic factors, phosphorylation, hormones and gender.

摘要

我们对药物反应中个体间和个体内变异性背后的机制的理解还不够充分。细胞色素 P450 药物代谢酶领域的进展引人注目,但药物转运体领域的进展却落后了。然而,目前人们对药物载体介导的药物处置的兴趣正在大幅上升。这一点在 2006 年 FDA 向制药行业发布的指导意见中得到了体现。该指导意见建议业界确定新型药物实体是否与转运体相互作用。这一建议可能源于这样一种观察,即几种新型克隆转运体对各种已批准药物的处置有重大影响。许多药物具有阴离子官能团,因此与有机阴离子转运体(OAT)相互作用。这些转运体共同在屏障上皮细胞中几乎普遍表达。此外,有几项报告表明,OATs 受到多种形式的调节,就像药物代谢酶和受体一样。因此,要深入了解患者和特定条件下对药物治疗的反应,关键是要全面描述 OAT 与药物和调节因子的相互作用。这篇综述为读者提供了关于克隆 OAT 的功能和底物特征的全面描述。此外,本综述的重点主要是 OAT 的调节,包括转录和表观遗传因素、磷酸化、激素和性别对 OAT 的影响。

相似文献

1
Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.有机阴离子转运体:发现、药理学、调控及在病理生理学中的作用。
Biopharm Drug Dispos. 2010 Jan;31(1):1-71. doi: 10.1002/bdd.693.
2
Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors.PDZ衔接蛋白和核受体对药物转运体的调控
Eur J Pharm Sci. 2006 Apr;27(5):487-500. doi: 10.1016/j.ejps.2005.11.006. Epub 2006 Jan 11.
3
Towards an understanding of organic anion transporters: structure-function relationships.迈向对有机阴离子转运体的理解:结构-功能关系
Med Res Rev. 2004 Nov;24(6):762-74. doi: 10.1002/med.20014.
4
Structure, function, and regulation of renal organic anion transporters.肾脏有机阴离子转运体的结构、功能及调控
Med Res Rev. 2002 Nov;22(6):602-16. doi: 10.1002/med.10019.
5
Update on the molecular physiology of organic anion transporters.有机阴离子转运体的分子生理学进展
Curr Opin Nephrol Hypertens. 2008 Sep;17(5):499-505. doi: 10.1097/MNH.0b013e32830b5d5d.
6
Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.肾脏及其他组织中OAT有机阴离子转运体对药物和毒物的处理
Nat Clin Pract Nephrol. 2007 Aug;3(8):443-8. doi: 10.1038/ncpneph0558.
7
The molecular pharmacology of organic anion transporters: from DNA to FDA?有机阴离子转运体的分子药理学:从基因到美国食品药品监督管理局?
Mol Pharmacol. 2004 Mar;65(3):479-87. doi: 10.1124/mol.65.3.479.
8
Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.胆汁盐诱导的胆汁淤积性肝炎中大鼠有机阴离子转运体的调节:熊去氧胆酸的作用
Hepatology. 2003 Jul;38(1):187-95. doi: 10.1053/jhep.2003.50256.
9
Human renal organic anion transporter 4 operates as an asymmetric urate transporter.人类肾脏有机阴离子转运体4作为一种不对称尿酸转运体发挥作用。
J Am Soc Nephrol. 2007 Feb;18(2):430-9. doi: 10.1681/ASN.2006040415. Epub 2007 Jan 17.
10
Organic anion transporters and their implications in pharmacotherapy.有机阴离子转运体及其在药物治疗中的意义。
Pharmacol Rev. 2012 Jul;64(3):421-49. doi: 10.1124/pr.111.004614. Epub 2012 Mar 28.

引用本文的文献

1
Effect of Hepatic Impairment on the Pharmacokinetics of Baicalin in Rats: Critical Roles of Gut Microbiota and Hepatic Transporters.肝损伤对大鼠黄芩苷药代动力学的影响:肠道微生物群和肝脏转运体的关键作用
Pharmaceutics. 2025 Jun 29;17(7):851. doi: 10.3390/pharmaceutics17070851.
2
An Evaluation of Cation-Chloride Cotransporters NKCC1 and KCC2 in Carbamazepine-Resistant Rats.卡马西平耐药大鼠中阳离子-氯离子共转运体NKCC1和KCC2的评估
Int J Mol Sci. 2025 May 16;26(10):4764. doi: 10.3390/ijms26104764.
3
Contribution and expression of renal drug transporters in renal cell carcinoma.
肾药物转运体在肾细胞癌中的作用及表达
Front Pharmacol. 2025 Feb 17;15:1466877. doi: 10.3389/fphar.2024.1466877. eCollection 2024.
4
Kützing extract exhibits antioxidant, anti-inflammation, and anti-nitrosative stress against impairment of renal organic anion transport in an study.在一项研究中,屈青提取物对肾脏有机阴离子转运损伤具有抗氧化、抗炎和抗亚硝化应激作用。
Nutr Res Pract. 2024 Oct;18(5):633-646. doi: 10.4162/nrp.2024.18.5.633. Epub 2024 Jul 19.
5
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters.非典型四环素类药物Chelocardin和Amidochelocardin与肾脏药物转运体的相互作用。
ACS Pharmacol Transl Sci. 2024 Jun 11;7(7):2093-2109. doi: 10.1021/acsptsci.4c00183. eCollection 2024 Jul 12.
6
Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs.母胎中与药物脑分布相关的三磷酸腺苷结合盒和溶质载体转运蛋白的表达。
Adv Exp Med Biol. 2023;1428:149-177. doi: 10.1007/978-3-031-32554-0_7.
7
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.关于全氟和多氟烷基物质(PFAS)与健康和疾病中的肾脏转运蛋白相互作用的科学综述:对 PFAS 毒代动力学中人群变异性的影响。
Environ Health Perspect. 2023 Jul;131(7):76002. doi: 10.1289/EHP11885. Epub 2023 Jul 7.
8
ATP/ADP biosensor organoids for drug nephrotoxicity assessment.用于药物肾毒性评估的ATP/ADP生物传感器类器官
Front Cell Dev Biol. 2023 Mar 2;11:1138504. doi: 10.3389/fcell.2023.1138504. eCollection 2023.
9
Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad Methionil.LY404039(培莫沙肽甲硫氨酸的活性代谢物)经肾脏有机阴离子转运蛋白 1(OAT1)介导的药物相互作用预测。
Pharm Res. 2023 Nov;40(11):2499-2511. doi: 10.1007/s11095-022-03464-y. Epub 2023 Jan 12.
10
Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model.新型有机阴离子转运体1/3 CRISPR/Cas9双敲除大鼠模型的构建与评价
Pharmaceutics. 2022 Oct 27;14(11):2307. doi: 10.3390/pharmaceutics14112307.